Kymera Therapeutics, Inc.
IRAK degraders and uses thereof
Last updated:
Abstract:
The present invention provides compounds, compositions thereof, and methods of using the same.
Status:
Grant
Type:
Utility
Filling date:
2 Dec 2019
Issue date:
7 Jun 2022